The company has not filed an annual or quarterly report since its Q2 FY2023 10-Q, filed Aug 14, 2023. Its latest SEC filing is a 15-12G from Mar 27, 2024.
10-Q for Q2 FY2023, filed Aug 14, 2023
The sections below describe the company as of the FY2022 annual report.
Sold air purifiers and indoor-air systems to consumers, healthcare facilities, and businesses.
10-K for FY2022, filed Mar 31, 2023Molekule Group, Inc. (the “Company,” “Molekule,” “we,” “us” or “our”) is a pathogen elimination technology company on a mission to keep…View ↗
We currently offer four purifier products for sale: Pūrgo, Air Mini+, Air Pro and Air Pro Rx, as well as replaceable pre-filters and…View ↗
Corporate and medical facility channel. We market and offer products and services to businesses seeking air purification solutions for…View ↗
Consumers bought directly through the company website or through retail partners; the company also marketed products and services to businesses and medical facilities.
10-K for FY2022, filed Mar 31, 2023Retail channel. We offer Molekule products in more than 10 countries and throughout some of the largest retailers in the United States. We…View ↗
Consumer direct channel. We market our products directly to consumers through online and offline advertising campaigns and marketing…View ↗
Corporate and medical facility channel. We market and offer products and services to businesses seeking air purification solutions for…View ↗
10-Q for Q2 FY2023, filed Aug 14, 2023
$13.2MView ↗
8-K, filed Oct 5, 2023
On October 4, 2023, the Company received written notice (the “Delisting Notice”) from the staff of The Nasdaq Stock Market LLC (“Nasdaq”)…View ↗
8-K, filed Oct 3, 2023
On October 3, 2023, Molekule Group, Inc. (the “Company”) and its wholly-owned subsidiary, Molekule, Inc., filed a voluntary petition in the…View ↗
8-K, filed Aug 14, 2023
On August 14, 2023, Molekule informed Aura that it was terminating the Merger Agreement, in accordance with Section 8.02 and Section…View ↗
Loading...